| PET-CT surveillance versus neck dissection in advanced head and neck cancer H Mehanna, WL Wong, CC McConkey, JK Rahman, M Robinson, ... New England Journal of Medicine 374 (15), 1444-1454, 2016 | 621 | 2016 |
| Randomized phase III trial of trastuzumab plus capecitabine with or without pertuzumab in patients with human epidermal growth factor receptor 2–positive metastatic breast … A Urruticoechea, M Rizwanullah, SA Im, ACS Ruiz, I Láng, G Tomasello, ... Journal of Clinical Oncology 35 (26), 3030-3038, 2017 | 117 | 2017 |
| The influence of MRI scan position on patients with oropharyngeal cancer undergoing radical radiotherapy S Hanvey, M McJury, LM Tho, M Glegg, M Thomson, D Grose, A James, ... Radiation oncology 8, 1-10, 2013 | 37 | 2013 |
| 12 week PET-CT has low positive predictive value for nodal residual disease in human papillomavirus-positive oropharyngeal cancers R Rulach, S Zhou, F Hendry, D Stobo, A James, MF Dempsey, D Grose, ... Oral oncology 97, 76-81, 2019 | 34 | 2019 |
| Trastuzumab-induced radiation recall dermatitis—first reported case RK Shrimali, NJ McPhail, PD Correa, J Fraser, M Rizwanullah Clinical Oncology 21 (8), 634-635, 2009 | 25 | 2009 |
| PHEREXA: A phase III study of trastuzumab (H)+ capecitabine (X)±pertuzumab (P) for patients (pts) who progressed during/after one line of H-based therapy in the HER2-positive … A Urruticoechea, M Rizwanullah, SA Im, AC Sanchez-Ruiz, I Lang, ... Journal of Clinical Oncology 34 (15_suppl), 504-504, 2016 | 18 | 2016 |
| Quantitative comparison of volumetric modulated arc therapy and intensity modulated radiotherapy plan quality in sino-nasal cancer M Sankaralingam, M Glegg, S Smith, A James, M Rizwanullah Journal of Medical Physics 37 (1), 8-13, 2012 | 18 | 2012 |
| Final overall survival (OS) analysis of PHEREXA: A randomized phase III trial of trastuzumab (H)+ capecitabine (X)±pertuzumab (P) in patients with HER2-positive metastatic … A Urruticoechea, M Rizwanullah, SA Im, AC Sánchez Ruiz, I Lang, ... Journal of Clinical Oncology 36 (15_suppl), 1013-1013, 2018 | 17 | 2018 |
| Sequential TPF chemotherapy followed by concurrent chemoradiotherapy in locally advanced head and neck cancer–a retrospective analysis of toxicity and outcomes IW Sanders, K Haslett, P Correa, C Paterson, A James, M Rizwanullah, ... Scottish medical journal 59 (1), 50-55, 2014 | 14 | 2014 |
| Lapatinib plus capecitabine versus trastuzumab plus capecitabine in the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer with central … JF Seligmann, A Wright-Hughes, A Pottinger, G Velikova, JB Oughton, ... Clinical Oncology 32 (10), 656-664, 2020 | 11 | 2020 |
| Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx: The MeRInO study C Paterson, S Allwood-Spiers, I McCrea, J Foster, M McJury, M Thomson, ... Clinical and Translational Radiation Oncology 2, 13-18, 2017 | 11 | 2017 |
| Dose-escalated intensity-modulated radiotherapy in patients with locally advanced laryngeal and hypopharyngeal cancers: ART DECO, a phase III randomised controlled trial CM Nutting, CL Griffin, P Sanghera, B Foran, M Beasley, D Bernstein, ... European Journal of Cancer 153, 242-256, 2021 | 10 | 2021 |
| Positron emission tomography-computed tomography surveillance after (chemo) radiotherapy in advanced head and neck squamous cell cancer: beyond the PET-NECK protocol S Zhou, R Rulach, F Hendry, D Stobo, A James, MF Dempsey, D Grose, ... Clinical Oncology 32 (10), 665-673, 2020 | 8 | 2020 |
| Neoadjuvant chemotherapy prior to surgery in head and neck cancer C Paterson, AG Robertson, D Grose, PD Correa, M Rizwanullah Clinical Oncology 24 (1), 79-80, 2012 | 8 | 2012 |
| Comparative cohort study of volumetric modulated arc therapy for squamous cell cancer of unknown primary in the head and neck—Involved neck only versus mucosal irradiation WY Poon, M Thomson, P McLoone, C Wilson, R Crosbie, S Schipani, ... Clinical Otolaryngology 45 (6), 847-852, 2020 | 3 | 2020 |
| Radiation therapy variation in the randomized phase 3 positron emission tomography neck study A Hartley, C Fong, P Sanghera, WL Wong, C McConkey, J Rahman, ... International Journal of Radiation Oncology, Biology, Physics 96 (2), S117, 2016 | 2 | 2016 |
| P163 Denosumab-induced hypocalcaemia in metastatic breast cancer J Fenech, I Macpherson, M Rizwanullah, G Lumsden, M Alfayez The Breast, S81, 2015 | 2 | 2015 |
| Positron emission tomography with computed tomography (PET-CT) to evaluate the response of bone metastases to non-surgical treatment PD Correa, RK Shrimali, S Han, M Rizwanullah Case Reports 2010, bcr1120092457, 2010 | 1 | 2010 |
| Nurse led, lung cancer oral chemotherapy clinic J McPhelim, JA Macphee, M Rizwanullah Lung Cancer, S16, 2008 | 1 | 2008 |
| EP-1137 DW MRI as biomarker of response during RT for intermed/high risk SCC oropharynx: a feasibility study C Paterson, I McCrea, L Hay, S Allwood-Speirs, L Devlin, ... Radiotherapy and Oncology 133, S631-S632, 2019 | | 2019 |
